PACIRA BIOSCIENCES, INC. Payments of Financing Costs
PACIRA BIOSCIENCES, INC. (PCRX) reported Payments of Financing Costs of $0 for the 12-month period ending 2015-12-31, per its 10-K filed 2016-02-25.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfFinancingCosts · last filed 2016-02-25
- PACIRA BIOSCIENCES, INC. payments of financing costs for the quarter ending 2014-12-31 was $0.00.
- PACIRA BIOSCIENCES, INC. payments of financing costs for the quarter ending 2014-09-30 was $0.00.
- PACIRA BIOSCIENCES, INC. payments of financing costs for the quarter ending 2014-06-30 was $0.00.
- PACIRA BIOSCIENCES, INC. payments of financing costs for the quarter ending 2014-03-31 was $0.00, a 100.00% decline year-over-year.
- PACIRA BIOSCIENCES, INC. payments of financing costs for fiscal 2015 was $0.00.
- PACIRA BIOSCIENCES, INC. payments of financing costs for fiscal 2014 was $0.00, a 100.00% decline from fiscal 2013.
- PACIRA BIOSCIENCES, INC. payments of financing costs for fiscal 2013 was $7.19M, a 426.81% increase from fiscal 2012.
- PACIRA BIOSCIENCES, INC. payments of financing costs for fiscal 2012 was $1.36M.
| Period end | Payments of Financing Costs 3 month | Payments of Financing Costs 6 month | Payments of Financing Costs 9 month | Payments of Financing Costs 12 month |
|---|---|---|---|---|
| 2015-12-31 | $0.00 10-K · filed 2016-02-25 | |||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | $0.00 derived: sum of 2 quarters · filed 2015-02-24 | $0.00 derived: sum of 3 quarters · filed 2015-02-24 | $0.00 10-K · filed 2015-02-24 |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30 | $0.00 derived: sum of 2 quarters · filed 2014-10-30 | $0.00 10-Q · filed 2014-10-30 | $0.00 derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-31 | $0.00 10-Q · filed 2014-07-31 | $0.00 derived: sum of 3 quarters · filed 2016-02-25 | $0.00 derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-03-31 | $0.00 10-Q · filed 2014-05-01 | $0.00 derived: sum of 2 quarters · filed 2016-02-25 | $0.00 derived: sum of 3 quarters · filed 2016-02-25 | $0.00 derived: sum of 4 quarters · filed 2016-02-25 |
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | $0.00 derived: sum of 2 quarters · filed 2016-02-25 | $0.00 derived: sum of 3 quarters · filed 2016-02-25 | $7.19M 10-K · filed 2016-02-25 |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30 | $0.00 derived: sum of 2 quarters · filed 2014-10-30 | $7.19M 10-Q · filed 2014-10-30 | $7.19M derived: sum of 4 quarters · filed 2015-02-24 |
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-31 | $7.19M 10-Q · filed 2014-07-31 | $7.19M derived: sum of 3 quarters · filed 2015-02-24 | $7.19M derived: sum of 4 quarters · filed 2015-02-24 |
| 2013-03-31 | $7.19M 10-Q · filed 2014-05-01 | $7.19M derived: sum of 2 quarters · filed 2015-02-24 | $7.19M derived: sum of 3 quarters · filed 2015-02-24 | $8.21M derived: sum of 4 quarters · filed 2015-02-24 |
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | $0.00 derived: sum of 2 quarters · filed 2015-02-24 | $1.02M derived: sum of 3 quarters · filed 2015-02-24 | $1.36M 10-K · filed 2015-02-24 |
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-31 | $1.02M derived: sum of 2 quarters · filed 2013-10-31 | $1.36M 10-Q · filed 2013-10-31 | |
| 2012-06-30 | $1.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | $1.36M 10-Q · filed 2013-08-06 | ||
| 2012-03-31 | $348.00K 10-Q · filed 2013-05-08 | |||
| 2011-12-31 | $0.00 10-K · filed 2014-02-25 | |||
| 2010-12-31 | $1.43M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-07 | $1.43M derived: sum of 2 quarters · filed 2013-03-07 | $1.79M 10-K · filed 2013-03-07 | |
| 2010-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-31 | $363.00K 10-Q · filed 2011-10-31 | ||
| 2010-06-30 | $363.00K 10-Q · filed 2011-08-11 | |||
| 2009-12-31 | $215.00K 10-K · filed 2012-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |